FC-Iro (Ferric Carboxymaltose) Injection

Description

Description

Fc-Iro 1000mg injection contains the active substance Ferric carboxymaltose. It belongs to the group of medications called iron replacement products. It is used to treat iron-deficiency anemia (decreased RBC due to lower levels of iron in the body) in adults and pediatric patients who cannot tolerate oral iron or when oral iron supplements are ineffective. It is also indicated to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis. This medicine is not recommended for pediatric patients less than one year of age.

Date of Approval

The FDA approved ferric carboxymaltose (Injectafer) for the treatment of iron deficiency anemia on July 25, 2013. The FDA approved Injectafer for other uses at later dates, including:
June 5, 2023: For the treatment of iron deficiency in adult patients with heart failure
December 16, 2021: For the treatment of iron deficiency anemia in pediatric patients
May 6, 2021: For the treatment of iron deficiency anemia in adult patients with a single dose option

Mechanism of Action of Ferric Carboxymaltose

Ferric carboxymaltose is a macromolecular ferric hydroxide carbohydrate complex, which allows for controlled delivery of iron within the cells of the reticuloendothelial system and subsequent delivery to the iron-binding proteins ferritin and transferrin.

Uses of Ferric Carboxymaltose

Ferric carboxymaltose injection is an iron replacement product that is used to treat iron deficiency anemia (not enough iron in the blood) in patients with non-dialysis dependent chronic kidney disease (CKD).

Ferric Carboxymaltose Dosage available

Fc-Iro 1000mg injection is an intravenously administered prescription drug. This injection will be given to you in a hospital or clinic setting. Your doctor will decide the dose, duration, and frequency of the administration based on your condition and other factors. Your doctor may perform a blood test to determine how much medicine you need.